IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Future Oncology

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on September 3, 2024

Impact Score

2023-2024

2.78

h-Index

2023-2024

 90

Rank

2023-2024

 4240

SJR

2023-2024

 1.029

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Future Oncology
Abbreviation Future Oncol.
Publication Type Journal
Subject Area, Categories, Scope Medicine (miscellaneous) (Q1); Cancer Research (Q2); Oncology (Q2)
h-index 90
Overall Rank/Ranking 4240
SCImago Journal Rank (SJR) 1.029
Impact Score 2.78
Publisher Taylor and Francis Ltd.
Country United Kingdom
ISSN 17448301, 14796694
Best Quartile Q1
Coverage History 2005-2023




About Future Oncology


Future Oncology is a journal covering the technologies/fields/categories related to Medicine (miscellaneous) (Q1); Cancer Research (Q2); Oncology (Q2). It is published by Taylor and Francis Ltd.. The overall rank of Future Oncology is 4240. According to SCImago Journal Rank (SJR), this journal is ranked 1.029. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 90. The best quartile for this journal is Q1.

The ISSN of Future Oncology journal is 17448301, 14796694. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Future Oncology is cited by a total of 3137 articles during the last 3 years (Preceding 2023).


Future Oncology Impact IF 2023-2024


The Impact IF 2023 of Future Oncology is 2.78, which is computed in 2024 as per its definition. Future Oncology IF is decreased by a factor of 0.08 and approximate percentage change is -2.8% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Future Oncology Impact IF 2024 Prediction


Impact IF 2023 of Future Oncology is 2.78. If the same downward trend persists, Impact IF may fall in 2024 as well.


Impact IF Trend


Year wise Impact IF of Future Oncology. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2023 2.78
2022 2.86
2021 3.24
2020 2.64
2019 2.19
2018 1.83
2017 1.84
2016 1.90
2015 2.08
2014 2.27

Future Oncology h-index


  Table Setting

Future Oncology has an h-index of 90. It means 90 articles of this journal have more than 90 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Future Oncology ISSN


The ISSN of Future Oncology is 17448301, 14796694. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Future Oncology Rank and SCImago Journal Rank (SJR)


The overall rank of Future Oncology is 4240. According to SCImago Journal Rank (SJR), this journal is ranked 1.029. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Future Oncology by Year


Year SJR
2023/2024 Coming Soon
2023 1.029
2022 0.874
2021 0.836
2020 0.857
2019 0.837
2018 0.797
2017 0.759
2016 0.752
2015 0.964
2014 0.976

Ranking of Future Oncology by Year


Year Ranking
2023/2024 Coming Soon
2023 4240
2022 5209
2021 5379
2020 5484
2019 5600
2018 5919
2017 6176
2016 6218
2015 4685
2014 4494

Future Oncology Publisher


Table Setting

Future Oncology is published by Taylor and Francis Ltd.. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2005-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Future Oncology is Future Oncol.. This abbreviation ('Future Oncol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Future Oncology


If your research field is/are related to Medicine (miscellaneous) (Q1); Cancer Research (Q2); Oncology (Q2), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Future Oncology?

Future Oncology latest impact IF is 2.78. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 3.24 (2021) and 1.83 (2018), respectively, in the last 10 years. Moreover, its average IS is 2.36 in the previous 10 years.


What's the SCImago Journal Rank (SJR) of the Future Oncology?

The Future Oncology has an SJR (SCImago Journal Rank) of 1.029, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 1.029 in 2023 and the lowest being 0.752 in 2016. Furthermore, the average SJR of the Future Oncology over the previous 10-year period stands at 2.36.


What's the latest h-index of the Future Oncology?

The latest h-index of the Future Oncology is 90.


Who's the publisher of the Future Oncology?

The Future Oncology is published by the Taylor and Francis Ltd., with its country of publication being the United Kingdom.


What's the current ranking of the Future Oncology?

The Future Oncology is currently ranked 4240 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 4240 in 2023 and its lowest position of 6218 in 2016.


What's the abbreviation or short name for the Future Oncology?

The standard ISO4 abbreviation for the Future Oncology is Future Oncol..


Is the "Future Oncology" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Future Oncology is classified as a journal that the Taylor and Francis Ltd. publishes.


What's the scope or major areas of the Future Oncology?

The Future Oncology encompasses the following areas:

  • Medicine (miscellaneous)
  • Cancer Research
  • Oncology

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Future Oncology?

The Future Oncology is assigned the following International Standard Serial Numbers (ISSN): 17448301, 14796694.


What's the best quartile of the Future Oncology?

The best quartile for the Future Oncology is Q1 (2023).


What's the coverage history of the Future Oncology?

The Future Oncology coverage history can be summarized as follows: 2005-2023.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Criminal Justice Review journal 12054 SAGE Publications Inc. 42 1.10
Journal of Applied Business Research journal 25715 CIBER Institute 32 0.19
Entrepreneurship Theory and Practice journal 220 Wiley-Blackwell 198 15.69
Canadian Journal of Education journal 18985 Canadian Society for the Study of Education (CSSE) 43 0.58
Studies in Continuing Education journal 7550 Routledge 40 3.04
Natural Solutions trade journal 28581 Innovision Health Media 1 0.00
Indian Phytopathology journal 15501 Springer Nature 16 1.09
Biological Procedures Online journal 4092 BioMed Central Ltd 48 3.54
European Journal of Cancer, Supplement journal 6710 Elsevier Ltd 29 0.33
Poljoprivreda journal 21390 Faculty of Agriculture in Osijek 16 0.39

Check complete list




Year wise Impact Score (IS) of Future Oncology

Impact Score Table

Year Impact Score (IS)
2024/2025 Coming Soon
2023 2.78
2022 2.86
2021 3.24
2020 2.64
2019 2.19
2018 1.83
2017 1.84
2016 1.90
2015 2.08
2014 2.27



Top Journals/Conferences in Medicine (miscellaneous)

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

New England Journal of Medicine
Massachussetts Medical Society | United States

Nature Medicine
Nature Research | United Kingdom

Current Protocols in Bioinformatics
John Wiley & Sons Inc. | United States

MMWR supplements
Epidemiology Program Office | United States

Nature Reviews Immunology
Nature Publishing Group | United Kingdom

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Annals of Oncology
Elsevier Ltd | United Kingdom

Morbidity and Mortality Weekly Report
Department of Health and Human Services | United States

Nature Reviews Methods Primers
Springer Nature | United States

See All

Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Nature Cancer
Nature Research | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Molecular Cancer
BioMed Central Ltd | United Kingdom

JAMA Oncology
American Medical Association | United States

Cell Host and Microbe
Cell Press | United States

Journal of Hematology and Oncology
BioMed Central Ltd | United Kingdom

Neuro-Oncology
Oxford University Press | United Kingdom

See All

Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Annals of Oncology
Elsevier Ltd | United Kingdom

Lancet Oncology, The
Elsevier Ltd | United Kingdom

Nature Cancer
Nature Research | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Molecular Cancer
BioMed Central Ltd | United Kingdom

Journal of Thoracic Oncology
Elsevier Inc. | United States

See All